Dehydrostephanine Isolated from Stephania venosa Possesses Anti-Inflammatory Activity in Lipopolysaccharide-Activated RAW264.7 Macrophages
Stephania venosa (Blume) Spreng. is a medicinal herb wildly used as a folklore medicine in Thailand. Many studies have reported that S. venosa tuber revealed a variety of pharmacological activities including anti-malarial, anti-microbial, anti-cancer, anti-oxidant, and anti-inflammatory activities. In this study, we investigated the effects of (–)-stephanine and dehydrostephanine isolated from S. venosa tuber on anti-inflammation in lipopolysaccharide (LPS)-activated RAW264.7 macrophages. RAW264.7 cells were treated with (–)-stephanine and dehydrostephanine in the presence of LPS and cell viability was determined by MTT assay. The levels of inflammatory mediators, nitric oxide (NO) and pro-inflammatory cytokines were determined by Griess reagent and enzyme-linked immunosorbent assay, respectively. Pre-treatment of dehydrostephanine significantly suppressed NO secretion in LPS-activated RAW264.7 cells with the half-maximal NO inhibitory concentration (IC50) value of 26.81±0.25 μM. However, (–)-stephanine had IC50 value on the inhibition of NO secretion of >40 μM. In addition, dehydrostephanine at concentrations of 20 - 80 μM significantly reduced LPS-induced tumor necrosis factor-α, interleukin-1b, and interleukin-6 production in RAW264.7 cells. The present study showed that dehydrostephanine possesses the anti-inflammatory effect on LPS-activated RAW264.7 macrophages by suppression of inflammatory mediators. Dehydrostephanine may be a promising candidate compound for further investigation of a novel class of anti-inflammatory drug.
E Stylianou. Epigenetics of chronic inflammatory diseases. J. Inflamm. Res. 2019; 12, 1-14.
JL Schultze and P Rosenstiel. Systems medicine in chronic inflammatory diseases. Immunity 2018; 48, 608-13.
S Akira, S Uematsu and O Takeuchi. Pathogen recognition and innate immunity. Cell 2006; 124, 783-801.
GA Duque and A Descoteaux. Macrophage cytokines: Involvement in immunity and infectious diseases. Front. Immunol. 2014; 5, 491-502.
Z Wu, M Han, T Chen, W Yan and Q Ning. Acute liver failure: Mechanisms of immune-mediated liver injury. Liver Int. 2010; 30, 782-94.
G Marelli, A Sica, L Vannucci and P Allavena. Inflammation as target in cancer therapy. Curr. Opin. Pharmacol. 2017; 35, 57-65.
K Ingkaninan, P Phengpa, S Yuenyongsawad and N Khorana. Acetylcholinesterase inhibitors from Stephania venosa tuber. J. Pharm. Pharmacol. 2006; 58, 695-700.
JT Blanchfield, DPA Sands, CHL Kennard and KA Byriel. Characterisation of alkaloids from some Australian Stephania (Menispermaceae) species. Phytochemistry 2003; 63, 711-20.
S Yodkeeree, C Ooppachai, W Pompimon and P Limtrakul. O-Methylbulbocapnine and dicentrine suppress LPS-induced inflammatory response by blocking NF-κB and AP-1 activation through inhibiting MAPKs and Akt signaling in RAW264.7 macrophages. Biol. Pharm. Bull. 2018; 41, 1219-27.
PM Le, V Srivastava, TT Nguyen, B Pradines, M Madamet, L Mosnier, TT Trinh and H Lee. Stephanine from Stephania venosa (Blume) Spreng showed effective antiplasmodial and anticancer activities, the latter by inducing apoptosis through the reverse of mitotic exit. Phytother. Res. 2017; 31, 1357-68.
DK Semwal, R Badoni, R Semwal, SK Kothiyal, GJP Singh and U Rawat. The genus Stephania (Menispermaceae): Chemical and pharmacological perspectives. J. Ethnopharmacol. 2010; 132, 369-83.
J Kunitomo, M Oshikata and M Akasu. The alkaloids of Stephania cepharantha Hayata cultivated in Japan (ii) (author’s transl). Yakugaku Zasshi. 1981; 101, 951-5.
S Nantapap, C Loetchutinat, P Meepowpan, N Nuntasaen and W Pompimon. Antiproliferative effects of alkaloids isolated from the tuber of Stephania venosa via the induction of cell cycle arrest in mammalian cancer cell lines. Am. J. Applied Sci. 2010; 7, 1057-65.
S Yodkeeree, P Wongsirisin, W Pompimon and P Limtrakul. Anti-invasion effect of crebanine and O-methylbulbocapnine from Stephania venosa via down-regulated matrix metalloproteinases and urokinase plasminogen activator. Chem. Pharm. Bull. 2013; 61, 1156-65.
K Bunluepuech and S Tewtrakul. Anti-HIV-1 integrase activity of Thai medicinal plants in longevity preparations. Songklanakarin J. Sci. Tech. 2011; 33, 693-7.
M Manrique-Moreno, L Heinbockel, M Suwalsky, P Garidel and K Brandenburg. Biophysical study of the non-steroidal anti-inflammatory drugs (NSAID) ibuprofen, naproxen and diclofenac with phosphatidylserine bilayer membranes. Biochim. Biophys. Acta 2016; 1858, 2123-31.
A Serrano, G Ros and G Nieto. Bioactive compounds and extracts from traditional herbs and their potential anti-inflammatory health effects. Medicines 2018; 5, 76-84.
P Intayoung, P Limtrakul and S Yodkeeree. Antiinflammatory activities of crebanine by inhibition of NF-κB and AP-1 activation through suppressing MAPKs and Akt signaling in LPS-induced RAW 264.7 macrophages. Biol. Pharm. Bull. 2016; 39, 54-61.
D Hirayama, T Iida and H Nakase. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int. J. Mol. Sci. 2017; 19, 92-105.
J Yin, KL Valin, ML Dixon and JW Leavenworth. The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer. J. Immunol. Res. 2017; 2017, 5150678.
JN Sharma, A Al-Omran and SS Parvathy. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007; 15, 252-9.
J MacMicking, Q Xie and C Nathan. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997; 15, 323-50.
TA Samad, KA Moore, A Sapirstein, S Billet, A Allchorne, S Poole, JV Bonventre and CJ Woolf.
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410, 471-5.
BA Beutler. The role of tumor necrosis factor in health and disease. J. Rheumatol. Suppl. 1999; 57, 16-21.
F Schaper and S Rose-John. Interleukin-6: Biology, signaling and strategies of blockade. Cytokine Growth F. R. 2015; 26, 475-87.
C Gabay. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 2006; 8, S3.
DL Scott, F Wolfe and TW Huizinga. Rheumatoid arthritis. Lancet 2010; 376, 1094-108.
K Hamidzadeh, SM Christensen, E Dalby, P Chandrasekaran and DM Mosser. Macrophages and the recovery from acute and chronic inflammation. Annu. Rev. Physiol. 2017; 79, 567-92.
M Monteleone, JL Stow and K Schroder. Mechanisms of unconventional and secretion of IL-1 family cytokines. Cytokine 2015; 74, 213-8.
RA Balk. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit. Care Clin. 2000; 16, 337-52.
MX Wang, YL Liu, Y Yang, DM Zhang and LD Kong. Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Eur. J. Pharmacol. 2015; 747, 59-70.
H Wang, X Cheng, S Kong, Z Yang, H Wang, Q Huang, J Li, C Chen and Y Ma. Synthesis and structure-activity relationships of a series of aporphine derivatives with antiarrhythmic activities and acute toxicity. Molecules 2016; 21, 1555.
Copyright (c) 2019 Walailak Journal of Science and Technology (WJST)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.